目錄:MedChemExpress LLC>>生化試劑>> Phenylephrine | MCE
CAS | 59-42-7 | 純度 | 99.52% |
---|---|---|---|
分子量 | 167.21 | 分子式 | C?H??NO? |
供貨周期 | 現貨 | 規格 | 500 mg |
貨號 | HY-B0769 | 應用領域 | 醫療衛生,化工,生物產業,制藥/生物制藥 |
MCE 的所有產品僅用作科學研究或藥證申報,我們不為任何個人用途提供產品和服務。
CAS No. : 59-42-7
產品活性:(R)-(-)-Phenylephrine is a selective α1-adrenoceptor agonist primarily used as a decongestant.
研究領域:GPCR/G Protein | Neuronal Signaling
作用靶點:Adrenergic Receptor
In Vitro: (R)-(-)-Phenylephrine is a selective α1-adrenoceptor agonist with pKi values of 5.86, 4.87 and 4.70 for α1D, α1B and α1A receptors respectively. Phenylephrine promotes cardiac fibroblast proliferation. Phenylephrine activates CaN and evokes NFAT3 nuclear translocation. It suggests that the Ca(2+)/CaN/NFAT pathway mediates phenylephrine -induced cardiac fibroblast proliferation, and this pathway might be a possible therapeutic target in cardiac fibrosis.
In Vivo: Perfusion of hearts with 100 μM phenylephrine causes a rapid (maximal at 10 min) 12-fold activation of two p38-MAPK isoforms. α1-adrenoceptor agonists such as phenylephrine increase the contractility of the heart. Phenylephrine also activates SAPKs/JNKs in neonatal ventricular myocytes. Phenylephrine could increase the alveolar fluid clearance in high tidal volume-ventilated rats and accelerate the absorption of pulmonary edema.
相關產品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Neuronal Signaling Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Antiviral Compound Library | Drug Repurposing Compound Library | Anti-Cardiovascular Disease Compound Library | Endocrinology Compound Library | Orally Active Compound Library | Neurotransmitter Receptor Compound Library | FDA Approved & Pharmacopeial Drug Library | Drug-Induced Liver Injury (DILI) Compound Library | Anti-Obesity Compound Library | Rare Diseases Drug Library | Children’s Drug Library | Antidepressant Compound Library | EMA-Approved Drug Library | FDA-Approved Anticancer Drug Library | Human Metabolite Library | Non-steroidal Anti-Inflammatory Compound Library | Off-patent Drug Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Perphenazine-d8 (dihydrochloride) | Desglymidodrine | PF-610355 | Adrenaline sulfate | Nadolol | Todralazine | Amibegron hydrochloride | N-5984 | Zotepine | Paliperidone-d4 | Yohimbine | Clenproperol-d7 | (R)-(+)-Atenolol | Salbutamol | Formoterol fumarate | Metoprolol-d6 (tartrate) | Clonidine-d4 (hydrochloride) | Pindolol-d7 | Clorprenaline | Trifluoperazine dihydrochloride | Bromchlorbuterol hydrochloride | Paliperidone | Navafenterol | Droxidopa-13C2,15N (hydrochloride) | Ecopipam | Alfuzosin-d3 | Synephrine | Romifidine | Idazoxan hydrochloride
熱門產品線:重組蛋白 | 化合物庫 | 天然產物 | 熒光染料 | PROTAC | 同位素標記物 | 寡核苷酸 | 抗體 | 點擊化學
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,我們致力于為*科研客戶提供前沿的高品質小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領;
• 產品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產品,廣泛應用于新藥研發、生命科學等科研項目;
• 提供虛擬篩選,離子通道篩選,代謝組學分析檢測分析,藥物篩選等專業技術服務;
• 設有專業的實驗中心和嚴格的質控、驗證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質檢報告,確保產品的高純度、高品質;
• 產品的生物活性多經各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業團隊跟蹤新的制藥及生命科學研究進展,為您提供*新的活性化合物;
• 與世界各大制藥公司及*科研機構建立了長期的合作。